AstraZeneca PLC

AZN

Equity

ISIN US0463531089 / Valor 163523

NASDAQ (2024-09-18)

USD 78.58+0.06%

AstraZeneca PLC
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

AstraZeneca PLC is a global pharmaceutical company engaged in the discovery, development, and commercialization of prescription medicines across various therapy areas, including oncology, cardiovascular, renal, metabolism, respiratory, and immunology. The company emphasizes a science-led approach to healthcare, aiming to deliver innovative medicines that address significant unmet medical needs. AstraZeneca operates with a focus on three strategic priorities: advancing the science and innovation behind their therapies, driving growth and leadership in their chosen therapy areas, and promoting sustainability and ethical practices within their operations. The company's research and development efforts are geared towards creating next-generation therapeutics, leveraging advancements in biologics, nucleotide-based therapies, and cell therapies. AstraZeneca's business model is structured to facilitate accelerated decision-making and the rapid introduction of new medicines, with a significant commitment to improving patient access to their treatments globally.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

17.9%1Y

41.4%3Y

80.4%5Y

Performance

19.7%1Y

23.8%3Y

26.2%5Y

Volatility